Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001638643-25-000011
Filing Date
2025-10-29
Accepted
2025-10-29 16:14:20
Documents
1
Period of Report
2025-10-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1761768857.html 4  
1 FORM 4 wk-form4_1761768857.xml 4 5302
  Complete submission text file 0001638643-25-000011.txt   6798
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Issuer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 333 LAKESIDE DRIVE FOSTER CITY CA 94404
Business Address
O'Day Daniel Patrick (Reporting) CIK: 0001638643 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19731 | Film No.: 251430136